Cheniere Energy reports a fall in third-quarter profit-March 2024-www.financetom.com

Cheniere Energy reports a fall in third-quarter profit

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Cheniere Energy reports a fall in third-quarter profit

Nov 3, 2024 3:28 PM

Oct 31 (Reuters) - Cheniere Energy reported a

fall in its third-quarter profit on Thursday, hurt by lower

liquefied natural gas (LNG) margins.

The company reported net income attributable to Cheniere at

$893 million for the quarter ended Sept. 30, compared with $1.7

billion a year ago.

Previous page： Update: Amazon Says AWS CEO Adam Selipsky to Step Down, Matt Garman to Take Over Next page： FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Amazon Says AWS CEO Adam Selipsky to Step Down, Matt Garman to Take Over

May 14, 2024

10:07 AM EDT, 05/14/2024 (MT Newswires) -- (Updates to add details in the second and third paragraphs.) Amazon.com ( AMZN ) announced Tuesday that Adam Selipsky will step down as chief executive of AWS and that Matt Garman will replace him, effective June 3. Selipsky spent 15 years in AWS, while Garman has been with AWS for 18 years, most...

FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients

May 14, 2024

Tuesday, Dynavax Technologies Corporation ( DVAX ) provided a regulatory update for its supplemental Biologics License Application (sBLA) to include a four-dose HEPLISAV-B vaccine regimen for adults on hemodialysis. The FDA has issued a Complete Response Letter stating that the application did not provide sufficient data to fully evaluate the effectiveness or safety of a four-dose regimen of HEPLISAV-B. The CRL has...

Apellis Pharmaceuticals Enters Into Senior Secured Credit Facility With Sixth Street

May 14, 2024

10:02 AM EDT, 05/14/2024 (MT Newswires) -- Apellis Pharmaceuticals ( APLS ) said Tuesday it entered into a senior secured credit facility of up to $475 million with Sixth Street, with roughly $375 million financed at completion. Under the terms, Apellis can draw a further $100 million before September 2025, the biopharmaceutical company added. The new credit facility will mature...

Kirby Insider Sold Shares Worth $285,828, According to a Recent SEC Filing

May 14, 2024

10:01 AM EDT, 05/14/2024 (MT Newswires) -- Dorman Lynn Strahan, President, Kirby Engine Systems, on May 10, 2024, sold 2,470 shares in Kirby (KEX) for $285,828. Following the Form 4 filing with the SEC, Strahan has control over a total of 18,584 shares of the company, with 18,584 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/56047/000095017024059171/xslF345X03/ownership.xml Price: 114.25, Change: -0.16, Percent Change:...